Stroke Thrombectomy and Aneurysm Registry
Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Aug 3, 2021
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The Stroke Thrombectomy and Aneurysm Registry is a research study designed to gather information about patients who are having surgery for various brain injuries, such as blocked blood flow, abnormal blood vessel formations, and bleeding in the brain. By collecting data from patients around the world, the study aims to understand how different surgical techniques and tools affect recovery and overall outcomes. This information can help doctors make better decisions in the future and improve care for patients experiencing these serious health issues.
If you or a family member is between the ages of 1 and 120 and is scheduled for surgery to treat a brain vascular issue, you may be eligible to participate in this registry. There are no specific exclusions, meaning anyone undergoing the relevant procedure can join. Participants will be asked to share their experiences and outcomes after the surgery, which will contribute to valuable knowledge that can help others facing similar challenges. Your participation could make a meaningful difference in advancing medical understanding and treatment options for brain injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Undergoing surgical intervention for central nervous system vascular lesion
- • Between 1 and 120 years of age
- Exclusion Criteria:
- • No exclusion criteria
About Medical University Of South Carolina
The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Kansas City, Kansas, United States
Ann Arbor, Michigan, United States
Houston, Texas, United States
New Haven, Connecticut, United States
Boston, Massachusetts, United States
Philadelphia, Pennsylvania, United States
Seattle, Washington, United States
Charleston, South Carolina, United States
Boston, Massachusetts, United States
Chicago, Illinois, United States
Bronx, New York, United States
Iowa City, Iowa, United States
Boston, Massachusetts, United States
Fayetteville, Arkansas, United States
San Antonio, Texas, United States
Atlanta, Georgia, United States
Memphis, Tennessee, United States
Chicago, Illinois, United States
Jacksonville, Florida, United States
Morgantown, West Virginia, United States
Albany, New York, United States
Phoenix, Arizona, United States
Saint Louis, Missouri, United States
Louisville, Kentucky, United States
Philadelphia, Pennsylvania, United States
Chicago, Illinois, United States
Gainesville, Florida, United States
Louisville, Kentucky, United States
Basel, , Switzerland
Tampa, Florida, United States
Madrid, , Spain
Salt Lake City, Utah, United States
Tucson, Arizona, United States
New York, New York, United States
Gwangju, , Korea, Republic Of
Evanston, Illinois, United States
New Brunswick, New Jersey, United States
Buenos Aires, , Argentina
Portsmouth, New Hampshire, United States
Winston Salem, North Carolina, United States
Bloomington, Indiana, United States
Galveston, Texas, United States
Charlottesville, Virginia, United States
York, Pennsylvania, United States
Stony Brook, New York, United States
Plano, Texas, United States
Oklahoma City, Oklahoma, United States
Miami, Florida, United States
Göttingen, , Germany
Kansas City, Kansas, United States
Loma Linda, California, United States
New York, New York, United States
Raleigh, North Carolina, United States
Hyōgo, , Japan
Atlanta, Georgia, United States
New Brunswick, New Jersey, United States
Toledo, Ohio, United States
Shreveport, Louisiana, United States
Saskatoon, , Canada
Tucson, Arizona, United States
Buenos Aires, , Argentina
Montevideo, , Uruguay
Lisbon, , Portugal
Kingwood, Texas, United States
Pittsburgh, Pennsylvania, United States
Wyoming, Michigan, United States
Pennington, New Jersey, United States
Wilkes Barre, Pennsylvania, United States
Damietta, , Egypt
Patients applied
Trial Officials
Meredith Robinson, MS
Study Director
Medical University of South Carolina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials